Sara Cecco

503 total citations
13 papers, 351 citations indexed

About

Sara Cecco is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Sara Cecco has authored 13 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Immunology. Recurrent topics in Sara Cecco's work include HER2/EGFR in Cancer Research (3 papers), Biosimilars and Bioanalytical Methods (2 papers) and Hearing, Cochlea, Tinnitus, Genetics (1 paper). Sara Cecco is often cited by papers focused on HER2/EGFR in Cancer Research (3 papers), Biosimilars and Bioanalytical Methods (2 papers) and Hearing, Cochlea, Tinnitus, Genetics (1 paper). Sara Cecco collaborates with scholars based in Italy, Ukraine and Ireland. Sara Cecco's co-authors include Paolo Baldo, Elisa Giacomin, Paola Molin, Carolyn Dorée, Don McFerran, Renzo Lazzarini, Stefano Marastoni, Roberto Leone, Alberta Bergamo and Celine J. Marmion and has published in prestigious journals such as Cochrane Database of Systematic Reviews, International Journal of Molecular Sciences and JBIC Journal of Biological Inorganic Chemistry.

In The Last Decade

Sara Cecco

11 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sara Cecco Italy	8	120	99	92	76	57	13	351
Yue Zhan China	11	96 0.8×	133 1.3×	53 0.6×	24 0.3×	40 0.7×	26	352
Keisuke Konishi Japan	9	105 0.9×	71 0.7×	115 1.3×	48 0.6×	51 0.9×	25	373
José María Verdaguer Spain	11	91 0.8×	117 1.2×	193 2.1×	139 1.8×	19 0.3×	29	478
Tianyang Dai China	13	121 1.0×	168 1.7×	14 0.2×	27 0.4×	11 0.2×	28	476
Matthew A. Ingersoll United States	11	51 0.4×	132 1.3×	36 0.4×	18 0.2×	8 0.1×	18	304
Alexandra R. Harris United States	9	150 1.3×	159 1.6×	69 0.8×	18 0.2×	2 0.0×	17	430
Jacques Rouanet France	9	93 0.8×	40 0.4×	11 0.1×	11 0.1×	12 0.2×	24	227
Chi‐Shin Hwang Taiwan	10	19 0.2×	120 1.2×	56 0.6×	50 0.7×	3 0.1×	17	459
Wenxuan Wang China	10	16 0.1×	158 1.6×	22 0.2×	22 0.3×	20 0.4×	17	330
Nandini Acharya United States	6	357 3.0×	137 1.4×	13 0.1×	13 0.2×	13 0.2×	7	682

Countries citing papers authored by Sara Cecco

Since Specialization

Citations

This map shows the geographic impact of Sara Cecco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Cecco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Cecco more than expected).

Fields of papers citing papers by Sara Cecco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Cecco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Cecco. The network helps show where Sara Cecco may publish in the future.

Co-authorship network of co-authors of Sara Cecco

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Cecco. A scholar is included among the top collaborators of Sara Cecco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Cecco. Sara Cecco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Bartoletti, Michele, Serena Corsetti, Sara Cecco, et al.. (2025). Exceptional Response to Trastuzumab Deruxtecan (T-DXd) in HER2-Positive Metastatic Endometrial Cancer. Current Oncology. 32(11). 596–596.

Cecco, Sara, Michele Fusaroli, Lorenzo Gerratana, et al.. (2024). Emerging Toxicities of Antibody-Drug Conjugates for Breast Cancer: Clinical Prioritization of Adverse Events from the FDA Adverse Event Reporting System. Targeted Oncology. 19(3). 435–445. 15 indexed citations

Masini, Carla, et al.. (2024). Pharmacy Workload in Clinical Trial Management: A Preliminary Complexity Assessment Tool for Sponsored Oncology and Haematology Trials. Current Oncology. 31(5). 2867–2873.

Cecco, Sara, et al.. (2022). Genetic Therapy and Molecular Targeted Therapy in Oncology: Safety, Pharmacovigilance, and Perspectives for Research and Clinical Practice. International Journal of Molecular Sciences. 23(6). 3012–3012. 15 indexed citations

Bearz, Alessandra, et al.. (2019). Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Lung Cancer. Recent Patents on Anti-Cancer Drug Discovery. 14(3). 242–257. 6 indexed citations

Baldo, Paolo & Sara Cecco. (2017). Amatuximab and novel agents targeting mesothelin for solid tumors. OncoTargets and Therapy. Volume 10. 5337–5353. 33 indexed citations

Rossi, Roberta, Roberta Pozzi, Marien González‐Lorenzo, et al.. (2015). Tyrosine kinase inhibitors for unresectable hepatocellular carcinoma in adults. Cochrane Database of Systematic Reviews. 1 indexed citations

Cecco, Sara, et al.. (2014). Safety and efficacy evaluation of albumin-bound paclitaxel. Expert Opinion on Drug Safety. 13(4). 511–520. 28 indexed citations

Baldo, Paolo, Carolyn Dorée, Paola Molin, Don McFerran, & Sara Cecco. (2012). Antidepressants for patients with tinnitus. Cochrane Database of Systematic Reviews. 2012(9). CD003853–CD003853. 103 indexed citations

10.

Lauro, Vincenzo Di, et al.. (2012). Trastuzumab and Gemcitabine in Pretreated HER2 Overexpressing Metastatic Breast Cancer Patients: Retrospective Analysis of Our Series. Journal of Oncology. 2012. 1–6. 6 indexed citations

11.

Cecco, Sara, Elena Muraro, Elisa Giacomin, et al.. (2010). Cancer Vaccines in Phase II/III Clinical Trials: State of the Art and Future Perspectives. Current Cancer Drug Targets. 11(1). 85–102. 26 indexed citations

12.

Griffith, Darren M., Sara Cecco, Ennio Zangrando, et al.. (2008). Ruthenium(III) dimethyl sulfoxide pyridinehydroxamic acid complexes as potential antimetastatic agents: synthesis, characterisation and in vitro pharmacological evaluation. JBIC Journal of Biological Inorganic Chemistry. 13(4). 511–520. 32 indexed citations

13.

Baldo, Paolo, et al.. (2008). mTOR Pathway and mTOR Inhibitors as Agents for Cancer Therapy. Current Cancer Drug Targets. 8(8). 647–665. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact